Table 1.
Clinical characteristic’s | Prostate cancer (N = 50) | BPH (N = 40) |
---|---|---|
Age | ||
< 60 | 20 (40%) | 13 (32.5%) |
≥ 60 | 30 (60%) | 27 (67.5%) |
PSA level (ng/ml) | ||
Median < 20 | 16 (32.00%) | 36 (90%) |
High ≥ 20 | 34 (68.00%) | 4 (10%) |
Gleason Score | ||
≤ 7a | 29(58.00%) | – |
> 7b | 21 (42.00%) | – |
Metastasis | ||
Mc0 | 33 (66.00%) | – |
Mxd | 17 (33.00%) | – |
a≤ 7 = Low Gleason Score
b> 7 = High Gleason Score
cM0 = Non metastatic condition
dMx = Metastatic condition